Phase I-IIa, to Evaluate the Safety, Feasibility, and Efficacy of the Use of BIOCLEFT in the Treatment of Cleft Palate.
Phase I-IIa, to Evaluate the Safety, Feasibility, and Efficacy of the Use of BIOCLEFT in the Treatment of Cleft Palate.
Recruiting · NCT06408337 · Registry updated 2024-05-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I-IIa, to Evaluate the Safety, Feasibility, and Efficacy of the Use of BIOCLEFT in the Treatment of Cleft Palate. | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Mouth Abnormalities, Stomatognathic Diseases, Stomatognathic System Abnormalities, cleft lip, cleft lip/palate, lip disorder, mouth disorder | Recruiting | Phase 1 / Phase 2 | 2024-05-10 | NCT06408337 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Andalusian Network for Design and Translation of Advanced Therapies | 2 |
| Elisa María Cubiles Montero de Espinosa | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Hospital Virgen de las Nieves | Granada | Spain | 1 |